November 14-16, 2018
Indianapolis, IN
Biotechnology Innovation Organization (BIO)
Finnegan is a sponsor of the BIO IP Counsels Committee Conference, hosted by the Biotechnology Innovation Organization. Finnegan partners Howard Levine and Alissa Lipton will join the panel discussion “Obviousness-Type Double Patenting—Where Are We, and Is It Time for a Legislative Clarification?” and Howard Levine and Amanda Murphy will join the panel discussion “The Role of CRISPR in Agricultural, Industrial, and Medical Biotechnology—What Every Patent Practitioner Should Know.” The program will take place at the Conrad Hotel in Indianapolis, Indiana. For more information, or to register, please see BIO’s website.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.